Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Patients With Stage IV or Recurrent Endometrial Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03120624
Recruitment Status : Suspended (Per DSMC instructions - temporary closure until CAPA process is completed)
First Posted : April 19, 2017
Last Update Posted : May 20, 2022
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Mayo Clinic

No Study Results Posted on for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : June 1, 2023
Estimated Study Completion Date : July 15, 2023